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Abstract
Background: The main limitation in performing genome-wide gene-expression profiling is the assay of low-
expression genes. Approaches with high throughput and high sensitivity for assaying low-expression transcripts
are urgently needed for functional genomic studies. Combination of the suppressive subtractive hybridization
(SSH) and cDNA microarray techniques using the subtracted cDNA clones as probes printed on chips has greatly
improved the efficiency for fishing out the differentially expressed clones and has been used before. However, it
remains tedious and inefficient sequencing works for identifying genes including the great number of redundancy
in the subtracted amplicons, and sacrifices the original advantages of high sensitivity of SSH in profiling low-
expression transcriptomes.
Results: We modified the previous combination of SSH and microarray methods by directly using the subtracted
amplicons as targets to hybridize the pre-made cDNA microarrays (named as "SSH/microarray"). mRNA
prepared from three pairs of hepatoma and non-hepatoma liver tissues was subjected to the SSH/microarray
assays, as well as directly to regular cDNA microarray assays for comparison. As compared to the original SSH
and microarray combination assays, the modified SSH/microarray assays allowed for much easier inspection of
the subtraction efficiency and identification of genes in the subtracted amplicons without tedious and inefficient
sequencing work. On the other hand, 5015 of the 9376 genes originally filtered out by the regular cDNA
microarray assays because of low expression became analyzable by the SSH/microarray assays. Moreover, the
SSH/microarray assays detected about ten times more (701 vs. 69) HCC differentially expressed genes (at least
a two-fold difference and P < 0.01), particularly for those with rare transcripts, than did the regular cDNA
microarray assays. The differential expression was validated in 9 randomly selected genes in 18 pairs of hepatoma/
non-hepatoma liver tissues using quantitative RT-PCR. The SSH/microarray approaches resulted in identifying
many differentially expressed genes implicated in the regulation of cell cycle, cell death, signal transduction and
cell morphogenesis, suggesting the involvement of multi-biological processes in hepato-carcinogenesis.
Conclusion: The modified SSH/microarray approach is a simple but high-sensitive and high-efficient tool for
differentially profiling the low-expression transcriptomes. It is most adequate for applying to functional genomic
studies.
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Background
Microarray is a powerful technique for simultaneously
determining the expression of thousands of genes [1-3].
Such studies can quickly yield a genome-wide description
of mRNA expression, called transcriptomes, in a given cell
or tissue at a given physiologic or pathologic condition
[4]. Even though, one of the main challenges in such
genome-wide gene-expression profiling is the difficult
inspection of genes with rare transcripts.
On the other hand, PCR-based suppressive subtractive
hybridization (SSH) techniques are highly sensitive for
identifying differences in gene expression [5-9]. However,
the potentials of SSH in assaying dynamic changes of gene
expression in minute levels have never been addressed
before. In addition, SSH techniques are also restricted in
terms of limited specificity and difficulties in identifying
enriched genes. Combining the SSH technique with high-
throughput screening of the harvested clones through the
use of cDNA microarrays could greatly reduce the tedious
work for northern blot analysis, as well as the likelihood
of false-positive clones enriched via SSH [10]. Such com-
bined approaches by printing the clones obtained from
the SSH amplicones on chips have been successfully used
for profiling the differentiation of gene expression [10-
13]. Nevertheless, in such approaches, the genes of the
subtracted clones remain to be sequenced for identifica-
tion, and a large portion of redundancy in the enriched
amplicons must also be identified. Moreover, since the
targets used to hybridize the amplicon clones printed on
chips were the un-enriched cDNA pools rather than the
subtracted, enriched clones, such approaches would not
increase the sensitivity for detection of the low-expression
genes.
Herein, we report our modifications using the subtracted
amplicons as the targets to hybridize the pre-prepared
microarray chips for SSH/microarray analysis. Since all of
the probes on the microarray chips have been well charac-
terized, the hundreds and thousands of genes in the sub-
tracted amplicons can be determined by a single
hybridization. Moreover, the relative expression status
between the compared tissues for each gene can be aug-
mented and easily determined by combining the use of
the targets prepared both from forward and reverse sub-
tractions of SSH. We named this modified approach
"SSH/microarray" and used human hepatocellular carci-
noma as a model to demonstrate the feasibility of this
approach.
Results
The SSH/cDNA microarray versus regular cDNA 
microarray approaches
To conduct the comparative transcriptomic studies on
human hepatoma particularly for the genes at low-expres-
sion levels, we set out an approach as shown in Figure 1.
We used the PCR-based suppressive subtractive hybridiza-
tion to enrich the differentially expressed cDNA clones
between human hepatoma and non-hepatoma liver tis-
sues. The SSH was conducted both forwards using RNA
prepared from hepatoma and non-hepatoma liver tissues
as tester and driver, respectively, to yield the hepatoma (T-
N) subtracted amplicons, and reversely using the mRNA
prepared from non-hepatoma and hepatoma liver tissues
as tester and driver respectively to yield the non-hepatoma
(N-T) subtracted amplicons as well. Instead of the previ-
ously reported combination with cDNA microarray
approaches, in which clones in the subtracted cDNA
libraries were cloned and then printed on chips, we
directly labeled the subtracted T-N and N-T amplicons
and then used as targets to hybridize the pre-made micro-
array chips printed with the known 14,811 cDNA clones.
We named this modified approach as "SSH/microarray".
The same tissue RNA pairs and cDNA microarray chips
were also used for the regular cDNA microarray assays for
comparison. Since human hepatoma generally occurs in
patients of chronic hepatitis with/without cirrhosis, to
identify the genes implicated in the common biological
processes leading to hepatocellular carcinogenesis, we
selected three hepatoma patients with different underly-
ing liver disease. The first was with chronic hepatitis C and
cirrhosis, the second had chronic hepatitis B and cirrhosis,
and the third had chronic hepatitis B but no clinical or
histological evidence of cirrhosis.
Figure 2 demonstrates the representative results obtained
from the corresponding regular cDNA microarray and the
SSH/microarray assays. Of note, in the SSH/microarray
assays the genes in the subtracted T-N and N-T amplicons
were readily identified without tremendous sequencing
works, which were required for the original SSH and
microarray combination assays. In addition, many of the
clones, including those of the house-keeping genes, such
as β-actin and GAPDH, with unremarkable difference in
hybridization intensities by the regular cDNA microarray
assays were efficiently excluded from the subtracted
amplicons (Figure 2, indicated by white circles). This indi-
cated the efficiency of subtraction hybridization. Most
importantly, many of the clones with hybridization inten-
sity below the evaluation threshold by the regular cDNA
microarray approaches (hybridization intensities lower
than or close to the noise) became detectable by the SSH/
microarray method (Figure 2, indicated with red circles).
These observations suggested a more sensitive detection
of the low abundance transcripts using the SSH/microar-
ray assays.BMC Genomics 2006, 7:131 http://www.biomedcentral.com/1471-2164/7/131
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Experimental flowchart Figure 1
Experimental flowchart. Messenger RNA was prepared from hepatoma (T) and the corresponding non-hepatoma liver tis-
sues (N), and then subjected to 1) PCR-based suppressive subtractive hybridization (SSH) followed by using the resulted sub-
tracted cDNA libraries as targets for cDNA microarray analysis (the SSH/microarray), and 2) conventional cDNA microarray 
analysis. SSH was performed in both the forward (T as tester) and reverse (N as tester) direction to enrich up-regulated (T-N 
amplicon) as well as down-regulated transcriptomes (N-T amplicon) in human hepatoma, respectively. The two subtracted 
amplicons were labeled with fluorescent cy-dyes as targets for microarray analysis, in which dye-swapping approaches were 
used. The results thus obtained were then compared to those obtained from the conventional cDNA microarray assays. The 
differentially expressed genes were categorized into three groups: I) only detected by conventional cDNA microarray 
approaches, II) identified by both conventional cDNA microarray and SSH/microarray approaches, and III) only obtained from 
SSH/microarray assays. The results were further confirmed by qRT-PCR in 6 genes randomly selected from group III differen-
tially expressed genes.
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The SSH/microarray approach on low-expression and 
differentially expressed genes
To further address whether the SSH/microarray approach
was able to assay the expression of those genes with rare
transcripts, we selectively inspected those genes with low
expression. Of the total of 14,811 clones on the chips,
9376 clones that were filtered out for further analyses in
the regular cDNA microarray studies due to the low
hybridization intensity (intensities <500 unit after the
noise subtracted) (Figure 3A) were selected for examina-
tion of their hybridization intensity in the SSH/microar-
ray assays (Figure 3B). Of these, 5015 clones were
enriched via the SSH/microarray assays and could be ana-
lyzed for differential expression (intensities >500 unit
after the noise intensity subtracted) (Figure 3B &3C). That
is, the SSH/microarray approach allowed about 100%
more of the genes, most of which were low abundant, for
the subsequent analyses.
Since SSH specifically amplified the difference of gene
expression, the SSH/microarray approach should also be
able to identify more differentially expressed genes
between hepatoma and non-hepatoma liver tissues,
which were originally undetectable by the regular cDNA
microarray methods. As shown in Fig 3C, of the 5015 low-
expression genes identified only by the SSH/microarray
assays, we identified additional 512 and 1923 genes with
at least a 2-fold decrease and increase in hepatoma tissues,
respectively.
We further examined the sensitivity for detection of differ-
ential expression by both approaches. We compared the
ratio of Cy5/Cy3 intensity of each clone obtained from
the regular cDNA microarray assays to that obtained from
the SSH/microarray assays. As shown in Figure 4, a total of
3028 genes with a ratio lower than 2 folds (-1 < log2 < 1)
using the cDNA microarray assays had a ratio greater than
2 folds (log2 > 1 or < -1) using the SSH/microarray assays
The representative results of the regular cDNA microarray vs Figure 2
The representative results of the regular cDNA microarray vs. SSH/microarray assays. RNA were prepared from 
the hepatoma and para-hepatoma liver tissues of a patient with HCC. Left panels are the representative results obtained via 
the regular cDNA microarray assays using the Cy 5 and Cy3 labeled aRNA generated from hepatoma and non-hepatoma liver 
tissues, respectively. Right panels are the representative results obtained via the SSH/microarray assays using Cy3 and Cy5 to 
label the forward and reverse subtracted amplicons, respectively. Lower panels are the close views of the upper panels. White 
circles indicate the clones, which had equal Cy3 and Cy5 hybridization intensities in the conventional cDNA microarray assays 
but been subtracted away from the subtracted amplicons. Red circles mark the clones, which had low Cy5 and Cy3 hybridiza-
tion intensities in the conventional cDNA microarray but presented with differential expression in the subtracted amplicons.
Regular cDNA microarray SSH/microarrayBMC Genomics 2006, 7:131 http://www.biomedcentral.com/1471-2164/7/131
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(Figure 4, 1091 and 1937 genes indicated by the red box,
respectively). That is, using the modified SSH/microarray
approaches resulted in much more differentially
expressed genes, particularly for those with rare transcripts
that using the regular cDNA microarray approaches.
Identification of differentially expressed genes with low 
expression in human hepatoma
A total of 69 and 701 genes differentially expressed in
human hepatoma were finally identified (based on the
data derived from the three tissue pairs in duplicate with
log2 > 1 or < -1, and P < 0.01) by the regular cDNA micro-
array assays and by the SSH/microarray assays, respec-
tively (Figure 5 & see additional file 1). That is, the SSH/
microarray assays detected 10-fold more differentially
expressed genes, particularly for those low-expression
genes, than did the conventional cDNA microarray. To
confirm the differential expression of genes with low
expression identified by the SSH/microarray assays
(including 446 and 255 up- and down-regulated genes,
respectively), we quantified the relative expression level of
nine randomly selected genes, whose differential expres-
sion was detected by the SSH/microarray assays, in 18
pairs of HCC and the matched non-HCC liver tissues. We
found the results were consistent with those obtained
from SSH/microarray assays (Figure 6).
Detection of differential low-expression transcriptomes by the SSH/microarray Figure 3
Detection of differential low-expression transcriptomes by the SSH/microarray. A) Of the 14811 distinct genes on 
the chips, 9376 genes had hybridization intensities lower than 500 units (the defined low intensity threshold for exclusion from 
further microarray analysis) in a representative set of results of the conventional cDNA microarray assay. B)These low-expres-
sion genes were then subjected to re-calibration for their Cy3/Cy5 intensities in the SSH/microarray assay and 5015 genes 
became detectable in SSH assays (blue spots). C) The distribution of these 5015 low-expression genes identified only in the 
SSH/microarray assays, including 512 and 1923 genes down- and up-regulated in hepatoma tissues, respectively. The data pre-
sented in this figure were based on the results derived from patient 1, a case of chronic hepatitis C with cirrhosis and 
hepatoma.
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Gene ontology analysis of the HCC differentially 
expressed genes
We compared the HCC up- and down-regulated transcrip-
tomes identified by the SSH/microarray assays in accord-
ance with their potential molecular functions, implicated
biological processes and sub-cellular localization. As pre-
sented in Table 1, the HCC up-regulated transcriptomes
had strong association with the regulation of cell cycle
progression (19 vs 4, P = 0.052), transcription (44 vs. 13,
P = 0.040), nucleic acid metabolism (80 vs. 26, P = 0.009),
and protein metabolism (89 vs. 27, P = 0.002), while the
HCC down-regulated transcriptomes tended to be related
to loss of normal physiological function of the hepato-
cytes (complement and coagulation cascades, 0 vs. 11, P =
0.000), and impairment in cellular responses to extrinsic
stresses including wounding (4 vs. 12, P = 0.011) and
external biotic stimuli (10 vs. 15, P = 0.007), in cellular
defense activities (16 vs. 24, P = 0.000), and in maintain-
ing cell ion homeostasis (1 vs. 5, P = 0.021). In addition,
genes related to cell responses to external growth stimuli
and signal transduction (48 vs. 24, P > 0.05), and related
to cell morphogenesis and biogenesis (28 vs. 9, P > 0.05)
were more frequently found in the HCC up-regulated
transcriptomes. On the other hand, the HCC up-regulated
transcriptomes had more genes with their products dis-
tributed in cell nucleus (89 vs. 26, P = 0.001), while the
HCC down-regulated transcriptomes had more genes of
secreted proteins (4 vs. 15, P = 0.000).
Discussion
Microarray techniques are limited in the detection of
genes with low expression [14], while subtractive hybrid-
ization methods are restricted by their specificity and the
tremendous work needed for validating the results, as well
as for sequencing to identify genes. There have been many
reports using microarray techniques for rapid and high
throughput validation of the subtraction specificity of
SSH by spotting the enriched clones on the chips or mem-
branes [10-13,15-23]. However, such approaches would
not only require tremendously sequencing works to iden-
tify genes including a great number of redundant clones in
the subtracted amplicons, but also lose the sensitivity of
SSH techniques to detect the low abundance transcripts,
since the sensitivity of microarray analysis is determined
by the targets used to hybridize chips but not by the
probes printed on chips.
Herein we report our modified approaches. Instead of
using the subtracted clones as probes spotted on chips, we
directly labeled the enriched amplicons and used them as
targets to hybridize the pre-made microarray chips for
microarray analysis (named as "SSH/microarray" in this
report). This approach allowed us not only to readily
identify genes without tremendous sequencing works in
the subtracted amplicons regardless of many redundant
clones, but also to easily evaluate the subtraction effi-
ciency and specificity. Moreover, the SSH/microarray
approach made it possible to conduct a transcriptome-
wide identification of differentially expressed genes par-
ticularly for those with low expression. It has been
reported that the absolute expression level is not a crucial
determinant for identifying genes, while the relative dif-
ference in expression levels does impact on whether or not
a gene is recovered by subtractive hybridization [5,24]. In
this report using the SSH/microarray approach, we identi-
fied about ten times more of the differentially expressed
genes, particularly for those with low expression, in
human hepatoma. Our findings successfully demon-
strated the transcriptome-wide assays of differentially
expressed genes at low abundance. This simple but very
powerful approach would greatly facilitate future
researches on functional genomics [15,19,25].
One of the main concerns about SSH techniques is their
specificity. However, as combined with microarray tech-
Comparison of the relatively expression by regular cDNA  microarray vs Figure 4
Comparison of the relatively expression by regular 
cDNA microarray vs. the SSH/microarray. The distri-
bution of the ratios of Cy5/Cy3 intensities obtained by the 
conventional cDNA microarray assays vs. the SSH/microar-
ray assays is shown. Only the clones with significant Cy3 and 
Cy5 intensities in both assays were included in the analysis. 
The clones inside the red-boxes were those with their log2 
ratios < 1 and > -1 via the conventional cDNA microarray 
assays, while their log2 ratios > 1 or < -1 by the SSH/microar-
ray assays. The data presented were based on those derived 
from patient 1, a case of chronic hepatitis C with cirrhosis 
and hepatoma.
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niques, the subtraction efficiency can be readily evaluated.
As shown in Figure 2, the subtraction efficiency was deter-
mined by the rare presence of clones with equal hybridi-
zation intensities between the forward and reverse
amplicons, and by the consistent exclusion of the house-
keeping genes in the subtracted amplicons. The specificity
was further confirmed by quantification of the differential
gene expression between hepatoma and para-hepatoma
Table 1: Gene ontology classification of the HCC differentially expressed genes
Up-regulated genes* Down-regulated genes* P-value
Cell cycle 19 4 0.052
Regulation of apoptosis 8 1 0.121
Transcription & regulation of 
transcription
44 13 0.040
Signal transduction 48 24 0.777
Cell organizaiton & biogenesis 28 9 0.109
Purine & pyrimidine metabolism 80 26 0.009
Protein metabolism 89 27 0.002
Nuclear © 89 26 0.001
Chromosome © 83 0 . 4 3 2
Cytoskeleton © 18 5 0.128
Ubiquitin ligase complex © 71 0 . 1 7 0
Complement & coagulation 
cascades
01 1 0 . 0 0 0
Response to wounding 4 12 0.011
Defense response 16 24 0.000
Response to external biotic stimuli 10 15 0.007
Immune response 14 21 0.001
Cell ion homeostasis 1 5 0.021
Microsome © 26 0 . 4 4 2
Peroxisome © 14 0 . 0 5 1
Extra-cellular space © 41 5 0 . 0 0 0
*Based on 360 and 202 informative up- and down-regulated genes identified using the SSH/microarray in HCC.
© cellular components, based on 207 and 110 informative up- and down-regulated genes in human HCC, respectively.
P value was determined by Fisher's exact test.
The differentially expressed genes Figure 5
The differentially expressed genes. The genes differentially expression in human hepatoma were identified by either only 
the conventional cDNA microarray assays (26 genes) or SSH/microarray assays (658 genes), or both (43 genes). The results 
were derived from three pairs of hepatoma liver tissues with at least two-fold difference in gene expression and P < 0.01.
I II III
658 genes 26 genes
43 genes SSH/microarray assays
cDNA microarray assaysBMC Genomics 2006, 7:131 http://www.biomedcentral.com/1471-2164/7/131
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liver tissues using RT real-time PCR in the 9 randomly
selected genes, of which six (GBA, PTPRF, GNL3, ERBB3,
OGDH,  FMO3) were identified to be differentially
expressed only by the SSH/microarray assays, but not the
conventional cDNA microarrays assays
Of interest, using this novel approach, we identified many
of the genes potentially implicated in hepatocellular car-
cinogenesis, which were not previously identified by con-
ventional cDNA microarray assays. For examples, 18
genes (WT1,  NME2,  IGF2,  PPMIG,  GMNN,  PSMD2,
CDK4,  SFN,  CDC20,  CDC25C,  AIF1,  PINX1,  CDC2,
MSH2, PA2G4, ASPM, PAFAH1B1, DCTN3) implicated in
cell cycle regulation, 16 genes (PLG,  FABP3,  APEG1,
NCK1, RBBP4, NME2, CTBP1, FGA, IBFBP7, FGB, AIF1,
CXCL1, JAG1, PINX1, GRN, PBEF1) correlated with the
regulation of cell proliferation, 16 genes (HDAC1,
DNASE1,  NUDT2,  CTNNAL1,  HSAC1,  BIRC1,  FASTK,
IGFBP3,  TUBB,  TNFSF10,  TNFRSF11B,  CLU,  BFAR,
BCAP31,  BIRC2,  C9) involved in the pathways of cell
death, 35 genes (MYL4, APEG1, TTN, HTN1, MEST, EVL3,
VLDLR,  MYOG,  TNNI2,  HOXC11,  IGF2,  AHSG,  TTID,
BIRC1,  PAFAH1B1,  SYK,  LMNA,  TNFRSF11B,  FALZ,
BMP1,  ETS2,  NRD1,  CXCL1,  JAG1,  SEMA4G,  HEY1,
ZNF22,  CRMP1,  TEAD4,  IGFBP1,  IGFBP3,  IGFBP7,
PTGS1, NEUGRIN, CUGBP1) related to the regulation of
cell differentiation and embryonic development, and 59
genes (ASGR2,  CAP2,  RGS5,  ITGB4BP,  NCK1,  EVL3,
PLCG2,  EPHA7,  IGF2,  IFNGR2,  AHSG,  CAP1,  PTPRF,
CXCL2,  GNAI1,  TGFBR1,  NCSTN,  DOK1,  FRBB3,  SYK,
MC1R,  CD79B,  CSNKIE,  CD69,  AVPR1A,  GNB2L1,
ACVR1, BIRC2, FLT4, CXCL1, FAG1, PNOC, SLC9A3R1,
LANCL1, GNB3, ADORA2B, FGR, NCK1, RAB11A, PLCG2,
LOC91614,  PRKAR1A,  FLJ22595,  ARF3,  TYK2,
MAP3K7IP1,  MC1R,  TNFSF10,  ARF4,  VAV2,  AVPR1A,
GNB2L1,  MAPK10,  STMN1,  SNX17,  ADORA2B,  ECT2,
RGS5,  IGFBP3) associated with signal transduction in
response to extra-cellular proliferation and growth stimuli
were found. Our findings that differentially expressed
genes were related to multi-biological processes suggest
the complexity of the molecular mechanisms for hepato-
cellular carcinogenesis.
Conclusion
In this study, we modified the previously method of the
combination of the suppressive subtractive hybridization
and microarray techniques to differentially profile the
low-expression transcriptomes of human hepatocellular
carcinoma by directly labeling both of the reciprocal sub-
tracted amplicons as target for cDNA microarray assays.
Compared to SSH or previous SSH in conjunction with
microarray approaches, this modified approach provided
us with three additional advantages: 1) easy inspection of
the subtraction efficiency, 2) avoidance of tremendous
sequencing work for gene identification, 3) high sensitiv-
ity for identifying the low-expression, differentially
expressed genes. This approach allowed for the detection
of about ten times more of the differentially expressed
genes than did the regular cDNA microarray approach in
human hepatoma, particularly for those with low expres-
sion. Using this approach, we identified many genes
potentially implicated in human hepatocarcinogenesis,
which were not identified before. For its high efficiency
and high sensitivity, this SSH/microarray approach is
powerful for the rapid differentially profiling the low-
expression transcriptomes, and most adequate for apply-
ing to functional genomic studies.
Methods
Tissues and patients
For SSH and cDNA microarray analysis, hepatoma and
the corresponding non-cancerous liver tissues were
obtained from 3 patients who had liver surgery at the
Chang Gung Memorial Hospital. For reverse-transcription
real-time PCR, hepatoma and the matched non-hepatoma
liver tissues were obtained from additional 18 patients of
hepatoma. Diagnoses of HCC and non-hepatoma liver
tissues were based on histo-pathologic findings. The Inter-
nal Review Board for Medical Ethics of Chang Gung
Memorial Hospital approved the specimen collection pro-
cedures and informed consent was obtained from each
subject or subject's family.
Suppressive subtractive hybridization
Total RNA from hepatoma and the para-hepatoma liver
tissues and the poly(A) RNA was prepared as described
before [26,27]. SSH was performed with the Clontech
PCR-Select cDNA Subtraction Kit (Clontech Laboratories
Inc., Palo Alto, CA) as described by the manufacturer but
with the following modifications. Starting material con-
sisted of 2 μg hepatoma mRNA as tester and 2 μg non-
hepatoma liver tissue mRNA as driver, and vice versa. Pri-
mary and secondary PCR conditions were altered to
increase specificity of amplification according to either
plan A or B. Both A and B reduced the extension time and
the number of cycles of the primary PCR to 2 min and 26
cycles, respectively. The primary PCR products were
diluted 1/50 prior to use in the secondary PCR. All other
aspects of plan A were as per the instructions of the man-
ufacturer. Plan B diverged from plan A in two ways. First,
the initial cycle of primary PCR was performed using
annealing and extension times that had been reduced to
15 s and 1.5 min, respectively. Second, for subsequent
cycles, the denaturing time was increased to 10 s while the
annealing and extension times were reduced to 15 s and
1.5 min, respectively.
RNA labeling and microarray procedures
In this study, we used the GMRCL Human 15 K set, Ver-
sion 2 chips as previously described [28], which containedBMC Genomics 2006, 7:131 http://www.biomedcentral.com/1471-2164/7/131
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14,811 sequence-verified, human cDNA clones mapped
to 12,530 distinct genes. All of the samples for the regular
cDNA microarray or SSH/microarray assays were per-
formed with the dye-swapping microarray design for min-
imizing labeling bias and statistical variances of data. For
the regular cDNA microarray experiment, we used 2 μg of
the total RNA for labeling and hybridization using a
3DNA Array 350RP Detection kit (Genisphere, PA, USA).
For the SSH experiment, 1 μl subtractive PCR products
were labeled with Cy3 and Cy 5-dCTP (NEN, Boston, MA)
using random primers. Unincorporated fluorescent nucle-
otides were removed using a Qiaquick PCR purification
kit (Qiagen). The fluorescent-labeled DNAs were mixed
with 30 μg of human cot-1 DNA (Invitrogen) and 100 μg
yeast tRNA, precipitated and then resuspended in 30 μl of
Microarray Hybridization Buffer Version 2 (Amersham
Pharmacia). The hybridization solution was heated to
80°C for 10 min to denature the DNA and was then incu-
bated for 30 min at 37°C, allowing cot-1DNA and yeast
tRNA to block the repetitive sequences in genome probes.
The probes were hybridized to a human cDNA microarray
(GMRCL Human 15 K). We scanned the slides with a con-
focal scanner ChipReader (Virtek, Canada) and acquired
Quantification of relatively gene expression in human hepatoma Figure 6
Quantification of relatively gene expression in human hepatoma. A total of nine differentially expressed genes includ-
ing six (GBA, PTPRF, GNL3, ERBB3, OGDHL, FMO3 belonging to Class III) identified only by the SSH/microarray assays and three 
(C9, MT1F, MT1X belonging to class II) identified by both of the SSH/microarray and regular cDNA microarray assays were 
assayed for their relative expression between HCC and the corresponding non-HCC liver tissues of 18 patients of hepatoma 
using real-time semi-quantitative RT-PCR. The results are presented with the log2 values of the gene expression ratio's 
between HCC vs. the matched non-HCC liver tissues. Left panel is the relatively expression level of these genes initially deter-
mined by the SSH/microarray and regular cDNA microarray assays, respectively. Of note, the difference of the expression for 
the six genes belonging to Class III was originally only identified by the SSH/microarray assays, but not by the regular cDNA 
microarray assays.
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the spot and background intensities with the GenePix Pro
4.1 software (Axon Instruments, Inc., CA, USA). The
within-slide normalization was done using programs
written with MATLAB 6.5 software (The MathWorks, Inc.,
MA, USA).
Reverse-transcription real-time PCR
To validate the results obtained from the SSH/microarray
assays, we randomly selected six differentially expressed
genes identified only by the SSH/microarray assays and
three differentially expressed genes identified by both the
regular cDNA microarray and SSH/microarray assays for
the comparison of gene expression between hepatoma
and the corresponding non-hepatoma liver tissues in
eighteen patients of HCC using reverse transcription real-
time PCR (qRT-PCR). Total RNA was extracted from tis-
sues with Trizol reagents and reverse transcribed using the
SuperScript III first strand synthesis system (Invitrogen,
Carlsbad, CA). qRT-PCR was conducted using the ABI
PRISM 7000 sequence detection system (Applied Biosys-
tems). Pre-designed Assays on Demand TaqMan probes
and primer pairs for these 9 genes were obtained from
Applied Biosystems Incoporated (ABI) (Foster City, CA).
For each gene, two to four sets of Taq-Man probes and
primers were tested. The probes contained a 6-carboxy-
fluorescein phosphoramidite (FAM dye) label at the 5'
end of the gene and a minor groove binder and non-fluo-
rescent quencher at the 3' end. These were designed to
hybridize across exon junctions. As a result, no fluorescent
signal was generated by these assays when genomic DNA
was used as a substrate, which confirmed that the assays
measured only mRNA. Equal amounts of RNA were used
for all qRT-PCR reactions, which were performed in tripli-
cate, and 18S ribosomal RNAs were used as internal con-
trols.
Gene ontology analysis
All data (derived from three pairs of HCC and non-HCC
liver tissues in a dye-swapping approach) were filtered so
that 446 up-regulated and 255 down-regulated genes in
HCC with at least two-fold difference and p value less
than 0.01 were included in the further studies. After
removal of the un-annotated genes, a total of 360 and 202
HCC up- and down-regulated genes were subjected to the
subsequent gene ontology analyses. The two lists of the
differentially expressed genes were analyzed using the on-
line software FatiGo for comparative gene ontology cate-
gories including molecular function, biological process
and cellular component [29]. They were also imported
into the on-line software KEGG2 for pathway mapping
[30,31]. The statistical significance was defined as P < 0.01
between the HCC up- and down-regulated gene groups
using Fisher's exact test.
Abbreviations
SSH, suppressive subtractive hybridization; HCC, hepato-
cellular carcinoma
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